by John Conrad | Jan 14, 2022 | Policy News
As a result of the rising number of COVID-19 cases, the General Assembly canceled the session days that were scheduled for this week. However, and as expected, standing committees in both chambers held virtual hearings throughout the week. With respect to next week,...
by John Conrad | Oct 30, 2021 | iBIO News, Policy News
The Illinois General Assembly returned to Springfield for the second and final week of Veto Session. As such, it has now concluded its business for 2021. The General Assembly is not scheduled to reconvene until next year. Attached please find the House and Senate...
by John Conrad | Oct 21, 2021 | Policy News
Earlier this year, the Governor and General Assembly enacted changes to the Equal Pay Act of 2003 (820 ILCS 112) with enforcement powers conferred to the Illinois Department of Labor (IDOL). Under the new law Public Acts 101-656 and 102-036), all private sector...
by John Conrad | Oct 21, 2021 | Policy News
The Illinois General Assembly returned to Springfield this week, and both chambers convened Tuesday and Wednesday. During that time, there was limited committee and floor action in both chambers. The House and Senate were scheduled to convene tomorrow, but both...
by John Conrad | Oct 18, 2021 | Policy News
We need our elected leaders to lower patients’ out-of-pocket cost for innovative prescription drugs. Unfortunately, Congress is considering radical government price setting policies. If enacted, these provisions would: Drastically limit patient access to...
by John Conrad | Sep 20, 2021 | iBIO News, Policy News
The Illinois biosciences community is experiencing a renaissance. Fueled by public and private investment and the passion of our community’s members, we are experiencing unprecedented growth, For example, nearly one million square feet of Class A lab space currently...
